Life-years gained by reducing donor heart ischemic times

Transplantation

Volumn 87, Issue 2, 2009, Pages 243-248

  Goldsmith, Kimberley A ^a,b   Demiris, Nikolaos ^a   Gooi, Julian H ^c   Sharples, Linda D ^a,b   Jenkins, David P ^b   Dhital, Kumud K ^b   Tsui, Steven S L ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Heart transplantation; Ischemic time; Life years gained

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GRAFT SURVIVAL; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MORTALITY; ORGAN DONOR; PRIORITY JOURNAL; RISK FACTOR; ISCHEMIA; KAPLAN MEIER METHOD; MIDDLE AGED; ORGAN PRESERVATION; PROPORTIONAL HAZARDS MODEL; REGISTER; RISK ASSESSMENT; STATISTICS; TIME; TRANSPLANTATION; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; FEMALE; GREAT BRITAIN; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; ORGAN PRESERVATION; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RISK ASSESSMENT; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TREATMENT OUTCOME; WARM ISCHEMIA; YOUNG ADULT;

EID: 59649087880     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318190007d     Document Type: Article

References (22)

1. Kirklin JK, Naftel DC, Bourge RC, et al. Evolving trends in risk profiles and causes of death after heart transplantation: A ten-year multi-institutional study. J Thorac Cardiovasc Surg 2003; 125: 881.
2. Delgado DH, Rao V, Ross HJ. Donor management in cardiac transplantation. Can J Cardiol 2002; 18: 1217.
3. Evans RW, Manninen DL, Garrison LP Jr., et al. Donor availability as the primary determinant of the future of heart transplantation. JAMA 1986; 255: 1892.
4. Gore SM, Cable DJ, Holland AJ. Organ donation from intensive care units in England and Wales: Two year confidential audit of deaths in intensive care. BMJ 1992; 304: 349.
5. Goudarzi BM, Bonvino S. Critical care issues in lung and heart transplantation. Crit Care Clin 2003; 19: 209.
6. Goldsmith K, Sharples L, Sudarshan C, et al. Twenty-five years of heart transplantation at Papworth hospital: Changes in factors influencing short- and long-term survival over time. J Heart Lung Transplant 2007; 26: S205.
7. Hussey JC, Bonser RS, Rudge CJ, et al. Ischaemia time in cardiac transplantation:AUK national study. J Heart Lung Transplant 2006; 25: 115.
8. DeSanto LS, AmarelliC, Romano G, et al. Evolving practice patterns in heart transplantation: A single-center experience over 15 years. Transplant Proc 2004; 36: 627.
9. Hassanein WH, Zellos L, Tyrrell TA, et al. Continuous perfusion of donor hearts in the beating state extends preservation time and improves recovery of function. J Thorac Cardiovasc Surg 1998; 116: 821.
10. Taylor DO, Edwards LB, Boucek MM, et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-third official adult heart transplantation report-2006. J Heart Lung Transplant 2006; 25: 869.
11. TransMedics. Andover, MA: TransMedics, Inc; 2008. TransMedics: Heart Transplantation; 2008. Available at: http://www.transmedics. com/wt/page/heart. Accessed July 1, 2008.
12. Tenderich G, Tsui S, El-Banayosy A, et al. The 1-year follow-up results of the PROTECT patient population using the Organ Care System. J Heart Lung Transplant 2008; 27: 166.
13. Gooi JH, Sharples L, Goldsmith K, et al. The potential impact of reducing cold ischaemic time on cardiac transplant survival. J Heart Lung Transplant 2007; 26: S63.
14. Lunn DJ, Thomas A, Best N, et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility. Stat Comput 2000; 10: 325.
15. International Society for Heart and Lung Transplantation. Addison, TX: International Society for Heart and Lung Transplantation; 2006. Registries - Heart/Lung Registries - Slides - Overall heart and adult heart transplantationstatistics; 2006. Availableat: http://www.ishlt.org/registries/ slides.asp?slides=heartLungRegistry. Accessed August 7, 2008.
16. Demiris N, Sharples LD. Bayesian evidence synthesis to extrapolate survival estimates in cost-effectiveness studies. Stat Med 2006; 25:1960.
17. Schnitzler MA, Hauptman PJ, Takemoto SK, et al. The impact of cold ischemia time on the life-year benefit of heart transplant. Am J Transplant 2006; 6: 382.
18. Schnitzler MA, Buchanan PM, Burroughs TE, et al. Impact of ischemia time on the outcomes of heart transplant. J Heart Lung Transplant 2007; 26: S64.
19. Rudge CJ. Transplantation of organs: Natural limitations, possible solutions - AUK perspective. Transplant Proc 2003; 35: 1149.
20. Ullah S, Zabala L, Watkins B, et al. Cardiac organ donor management. Perfusion 2006; 21: 93.
21. McCurry K, Jeevanandam V, Mihaljevic T, et al. Prospective multicenter safety and effectiveness evaluation of the Organ Care System device for cardiac use (PROCEED). J Heart Lung Transplant 2008; 27: 166.
22. Sharples L, Buxton M, Caine N, et al. Evaluation of the ventricular assist device programme in the UK. Health Technol Assess 2006; 10.